eHealthNews.eu proudly presents the top 20 most popular breaking eHealth news from 2018. Have a wonderful 2019 New(s) Year filled with health, happiness, and spectacular success!
Read more ...
re.flex Brings Telerehabilitation Assistants to the Healthcare Market
The surgical treatment of musculoskeletal conditions is at a high level thanks to continuous improvements in research and clinical care. The same applies to postoperative physiotherapy, which supports patients in their healing process. Most important for a comprehensive recovery however, are the patients themselves - through independent training outside the prescribed therapy sessions.
Read more ...
EIT Health Looks to Create New Business Ventures Addressing the Way we Manage Mental and Brain Health and Use Digital Biomarkers for Diagnostics
EIT Health, a network of best-in-class innovators backed by the EU, has announced the second year of its innovation programme, Wild Card. The second year of high-risk innovation programme Wild Card kicks off this week, challenging talent to deliver real solutions to the healthcare market.
Read more ...
FDA Clears Mobile Medical App to Help those with Opioid Use Disorder Stay in Recovery Programs
Today, the U.S. Food and Drug Administration cleared a mobile medical application (app) to help increase retention (the amount of time a patient participates) in an outpatient treatment program for individuals with opioid use disorder (OUD). The reSET-O app is a prescription cognitive behavioral therapy intended to be used in addition to outpatient treatment under the care of a health care professional,
Read more ...
German Accelerator Life Sciences (GALS) Alumni Company SpinDiag Closes € 3M Funding Round
German Accelerator Life Sciences Alumni company, SpinDiag, just announced the successful closing of 3 million Series A funding round. The Freiburg-based health tech startup addresses the challenge of patients introducing drug-resistant bacteria into hospitals. SpinDiag provides a rapid point-of-care screening system, SpinDiag one, to test high-risk patients for all relevant drug-resistances.
Read more ...
FDA Grants Breakthrough Device Designation to Artificial Intelligence Software for CTEPH Pattern Recognition from Bayer and MSD
Bayer announced that the U.S. Food and Drug Administration (FDA) granted Breakthrough Device Designation to the Artificial Intelligence Software for Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Pattern Recognition, which Bayer is currently developing jointly with MSD (tradename of Merck & Co., Inc., Kenilworth, N.J., USA).
Read more ...
Syntropy to Unlock the Value of Scientific Data in Fight to End Cancer
Merck, a leading science and technology company, and software company Palantir Technologies, today announced their intent to form a joint venture under the brand name Syntropy. Syntropy is expected to empower scientists and research centers with a collaborative technology platform to advance cancer research, help drive scientific discovery, and improve human lives.
Read more ...